Bristol-Myers Squibb this afternoon is acquiring a young startup, IFM Therapeutics, in an unusual deal that will also see the big drugmaker get a chance to own rights in a new company the biotech is spinning out as well. New York-based Bristol (NYSE: BMY) will pay $300 million up front for IFM, which will give […]
NYS Entity Status
NYS Filing Date
AUGUST 06, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2013 - LG BRISTOL L.L.C.
AROUND THE WEB
- IFM Gets $300M Bristol Buyout, Plans Second Strike With New Spinout
By Ben Fidler - Thursday Aug 3, 2017
- The Top 10 Moments of New York Fashion Week
By THE NEW YORK TIMES - Friday Sep 15, 2017
Highlights from the shows, including a celebrity-packed front row at Calvin Klein and a trek to Bedford Hills, N.Y., to see Ralph Lauren’s vintage cars.
- Women of Sex Tech, Unite
By ANNA NORTH - Friday Aug 18, 2017
New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.
- Man accused of burning girl with iron over wrinkled clothes
By Associated Press - Friday Jul 28, 2017
BRISTOL, Conn. — A Connecticut man has been arrested on charges that he intentionally burned his girlfriend’s 5-year-old daughter with an iron because she may have wrinkled his clothes. The Bristol Press reports that 33-year-old Victor Diaz, of Bristol, was arraigned Thursday on charges including assault and reckless endangerment. Investigators say he burned the girl...
- Latest Immunotherapy Setback: Bristol Drugs Stumble in Kidney Cancer
By Ben Fidler - Wednesday Aug 16, 2017
The recent stumbles for cancer immunotherapy—specifically, combinations of treatments meant to help boost its effectiveness—continued late Tuesday with some disappointing news from one of the leaders in the field, Bristol-Myers Squibb. Bristol (NYSE: BMY) said that a Phase 3 trial testing two of its immunotherapies together in newly diagnosed kidney cancer patients, a study called […]